Advanced search
Publication Cover
Future Microbiology Volume 5, 2010 - Issue 3
Submit an article Journal homepage
295
Views
0
CrossRef citations to date
0
Altmetric
Priority Paper Evaluation

Towards a Vaccine Against Escherichia Coli-Associated Urinary Tract Infections

Laura Serinoa Novartis Vaccines & Diagnostics, Research Centre, Via Fiorentina 1, 53100 Siena, Italy.Tel.: +39 0577 245 547 Fax: +39 0577 243 [email protected]
,
Danilo Gomes Morielb Novartis Vaccines & Diagnostics, Research Centre, Via Fiorentina 1, 53100 Siena, Italy.Tel.: +39 0577 243 847 Fax: +39 0577 243 [email protected]
,
Rino Rappuolic Novartis Vaccines & Diagnostics, Research Centre, Via Fiorentina 1, 53100 Siena, Italy.Tel.: +39 0577 243 414 Fax: +39 0577 243 [email protected]
&
Mariagrazia Pizzad Novartis Vaccines & Diagnostics, Research Centre, Via Fiorentina 1, 53100 Siena, Italy.Tel.: +39 0577 243 087 Fax: +39 0577 243 [email protected]
Pages 351-354 | Published online: 08 Mar 2010

Bibliography

  • Alteri CJ , HaganEC, SivickKE, SmithSN, MobleyHL: Mucosal immunization with iron receptor antigens protects against urinary tract infection.PLoS Pathog.5(9) , E1000586 (2009).
  • Hooton TM , StammWE: Diagnosis and treatment of uncomplicated urinary tract infection.Infect. Dis. Clin. North Am.11(3) , 551–581 (1997).
  • Hopkins WJ , ElkahwajiJ, BeierleLM, LeversonGE, UehlingDT: Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.J. Urol.177(4) , 1349–1353 (2007).
  • Langermann S , BallouWR: Development of a recombinant fimch vaccine for urinary tract infections.Adv. Exp. Med. Biol.539(Pt B) , 635–648 (2003).
  • Roberts JA , KaackMB, BaskinG et al.: Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.J. Urol.171(4) , 1682–1685 (2004).
  • Hagan EC , MobleyHL: Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.Infect. Immun.75(8) , 3941–3949 (2007).
  • Alteri CJ , MobleyHL: Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine.Infect. Immun.75(6) , 2679–2688 (2007).
  • Hagan EC , MobleyHL: Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection.Mol. Microbiol.71(1) , 79–91 (2009).
  • Russo TA , CarlinoUB, JohnsonJR: Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli.Infect. Immun.69(10) , 6209–6216 (2001).
  • Russo TA , McfaddenCD, Carlino-MacdonaldUB, BeananJM, BarnardTJ, JohnsonJR: IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.Infect. Immun.70(12) , 7156–7160 (2002).
  • Hancock V , FerrieresL, KlemmP: The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine.Microbiology154(Pt 1) , 167–175 (2008).
  • Russo TA , McfaddenCD, Carlino-MacdonaldUB, BeananJM, OlsonR, WildingGE: The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.Infect. Immun.71(12) , 7164–7169 (2003).
  • Durant L , MetaisA, Soulama-MouzeC, GenevardJM, NassifX, EscaichS: Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.Infect. Immun.75(4) , 1916–1925 (2007).
  • Uehling DT , WolfL: Enhancement of the bladder defense mechanism by immunization.Invest. Urol.6(5) , 520–526 (1969).
  • Langermann S , MollbyR, BurleinJE et al.: Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.J. Infect. Dis.181(2) , 774–778 (2000).
  • O‘Hanley P , LalondeG, JiG: α-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an α-hemolysin vaccine in preventing renal injury in the Balb/c mouse model of pyelonephritis.Infect. Immun.59(3) , 1153–1161 (1991).
  • Uehling DT , HopkinsWJ, ElkahwajiJE, SchmidtDM, LeversonGE: Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.J. Urol.170(3) , 867–869 (2003).
  • Bauer HW , AlloussiS, EggerG, BlumleinHM, CozmaG, SchulmanCC: A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections.Eur. Urol.47(4) , 542–548 (2005).
  • Billips BK , YaggieRE, CashyJP, SchaefferAJ, KlumppDJ: A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.J. Infect. Dis.200(2) , 263–272 (2009).
  • Uehling DT , HopkinsWJ, JensenJ, BalishE: Vaginal immunization against induced cystitis in monkeys.J. Urol.137(2) , 327–329 (1987).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.